JP2001019606A - Warmth sensory pack - Google Patents
Warmth sensory packInfo
- Publication number
- JP2001019606A JP2001019606A JP11191154A JP19115499A JP2001019606A JP 2001019606 A JP2001019606 A JP 2001019606A JP 11191154 A JP11191154 A JP 11191154A JP 19115499 A JP19115499 A JP 19115499A JP 2001019606 A JP2001019606 A JP 2001019606A
- Authority
- JP
- Japan
- Prior art keywords
- weight
- cosmetic
- parts
- pack
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Cosmetics (AREA)
Abstract
Description
【０００１】[0001]
【発明の属する技術分野】本発明は、パックなどに好適
な化粧料に関する。TECHNICAL FIELD The present invention relates to cosmetics suitable for packs and the like.
【０００２】[0002]
【従来の技術】パック或いはマッサージなどの化粧行為
時に重要な要素の一つに、温感を感じることがある。こ
れは、この様な化粧行為に於いて期待される効果に血行
促進作用があり、温感を感じることにより、この様な効
果の実感が具現され、その結果、この化粧行為そのもの
に大いなる満足を感じるためと、適度な温感が使用時の
心地よさを具現し、この快感によって、個人的な生態系
の環境を整え、健康上好ましい効果を発揮するためであ
る。この様な温感の具現化方法としては、従来知られて
いた技術としては、多量のグリセリン等の多価アルコー
ルを化粧料中に含有させ、このグリセリンが生体の水と
混和するときに生じる溶解熱を利用する方法や還元性酸
化鉄を含有させ、生体が有している水により酸化される
ときに生じる化学反応熱を利用する方法などが知られて
いるが、溶解熱はその熱の発生量が小さいため、感じる
温感は充分ではないという欠点を有し、酸化反応による
化学反応熱によるものは、熱の発生量のコントロールが
しにくく、アレルギーなどを引き起こす可能性のある鉄
イオンを多量に放出する欠点があったため、この様な欠
点を改良した温感化粧料の開発が望まれていた。2. Description of the Related Art One of the important factors during a makeup operation such as a pack or a massage is a feeling of warmth. This is because the effect expected in such a makeup act has a blood circulation promoting effect, and by feeling warmth, the realization of such an effect is embodied, and as a result, the great satisfaction in the makeup act itself is achieved. This is because the feeling and the moderate warmth realize the comfort at the time of use, and this pleasant feeling prepares a personal ecosystem environment and exerts a favorable effect on health. As a method of realizing such a warm feeling, a conventionally known technique is to incorporate a large amount of a polyhydric alcohol such as glycerin into a cosmetic and dissolve the glycerin when the glycerin is mixed with water of a living body. Known methods include the use of heat and the use of heat of chemical reaction that occurs when water is oxidized by water contained in living organisms, which contains reducible iron oxide. It has the drawback that the feeling of warmth is not enough due to the small amount, and the heat generated by the chemical reaction due to the oxidation reaction makes it difficult to control the amount of heat generated, and produces a large amount of iron ions that may cause allergies. Therefore, there has been a demand for development of a warming cosmetic which has improved such a defect.
【０００３】一方、酸化亜鉛等の酸と反応する金属化合
物及び／又は金属水酸化物とクエン酸のような酸性物質
とを水溶液で混合しない形態で含有する化粧料は全く知
られていなかったし、この様な化粧料が使用時温感を有
することは全く知られていなかった。On the other hand, there has been no known cosmetic composition containing a metal compound and / or a metal hydroxide which reacts with an acid such as zinc oxide and an acidic substance such as citric acid in a form not mixed with an aqueous solution. It has never been known that such cosmetics have a warm feeling when used.
【０００４】[0004]
【発明が解決しようとする課題】本発明はこの様な状況
下為されたものであり、充分且つ適切な熱量を発生し、
心地よい温感を有する化粧料を提供することを課題とす
る。SUMMARY OF THE INVENTION The present invention has been made under such circumstances, and generates a sufficient and appropriate amount of heat.
It is an object to provide a cosmetic having a comfortable warm feeling.
【０００５】[0005]
【課題の解決手段】本発明者らは、この様な状況に鑑み
て、充分且つ適切な熱量を発生し、心地よい温感を有す
る化粧料を求めて、鋭意研究努力を重ねた結果、酸と反
応する金属化合物及び／又は金属水酸化物と酸性物質と
を水溶液として混合しない形態で含有する、化粧料にそ
の様な特性を見いだし、発明を完成させるに至った。以
下、本発明について、実施の形態を中心に詳細に説明を
加える。SUMMARY OF THE INVENTION In view of such circumstances, the present inventors have intensively researched for cosmetics which generate a sufficient and appropriate amount of heat and have a comfortable feeling of heat. The present inventors have found such characteristics in a cosmetic containing a reacting metal compound and / or metal hydroxide and an acidic substance in a form not mixed as an aqueous solution, and have completed the invention. Hereinafter, the present invention will be described in detail focusing on embodiments.
【０００６】[0006]
【発明の実施の形態】（１）本発明の化粧料の必須成分
である両性物質 本発明の化粧料は両性物質を含有することを特徴とす
る。ここで、両性物質とは、金属酸化物及び／又は水酸
化物であって、酸とも塩基とも反応し、塩を形成する物
質のことを意味し、例えば、水酸化アルミニウム、酸化
アルミニウム、水酸化亜鉛、酸化亜鉛、酸化マグネシウ
ム、水酸化マグネシウム等が例示できる。これらの中で
特に好ましいものは化粧料の分野で長年にわたる使用実
績のある、酸化亜鉛及び／又は酸化マグネシウムであ
り、この２者では酸化亜鉛が特に好ましい。これは、そ
の使用実績により使用上の安全性が既に確認されている
からである。本発明に於いて使用される酸化亜鉛は、通
常化粧料で使用されているものであれば特段の限定はな
いが、熱発生特性から１μｍ以下の微粒子のものである
ことが好ましい。これは、表面積が大きく、反応がスム
ーズに進行するので、適切な温度を得られるからであ
る。本発明の化粧料に於いて、これら両性物質の好まし
い含有量は、使用直前の形態に於いて、１〜２０重量％
であり、更に好ましくは５〜１５重量％である。これ
は、両性物質が少なすぎると発生する熱量が充分ではな
い場合があり、多すぎると熱くなりすぎる場合があるか
らである。前記範囲に於いて快適な熱量が得られるので
ある。DESCRIPTION OF THE PREFERRED EMBODIMENTS (1) Amphoteric substance which is an essential component of the cosmetic of the present invention The cosmetic of the present invention is characterized by containing an amphoteric substance. Here, the amphoteric substance means a metal oxide and / or hydroxide, which reacts with an acid and a base to form a salt, for example, aluminum hydroxide, aluminum oxide, and hydroxide. Examples include zinc, zinc oxide, magnesium oxide, and magnesium hydroxide. Particularly preferred among these are zinc oxide and / or magnesium oxide, which have been used for many years in the field of cosmetics, and zinc oxide is particularly preferred for the two. This is because the safety in use has already been confirmed by the use results. The zinc oxide used in the present invention is not particularly limited as long as it is generally used in cosmetics, but is preferably a fine particle of 1 μm or less in view of heat generation characteristics. This is because the surface area is large and the reaction proceeds smoothly, so that an appropriate temperature can be obtained. In the cosmetic of the present invention, the preferable content of these amphoteric substances is 1 to 20% by weight in the form immediately before use.
And more preferably 5 to 15% by weight. This is because if the amount of the amphoteric substance is too small, the amount of generated heat may not be sufficient, and if the amount is too large, the substance may become too hot. A comfortable amount of heat can be obtained in the above range.
【０００７】（２）本発明の化粧料の必須成分である酸
性物質 本発明の化粧料は、酸性物質を必須成分として含有す
る。本発明で使用できる酸性物質としては、前記両性物
質と反応し塩を形成するものであれば、特段の限定無く
使用することができ、例えば、希塩酸等の希薄鉱酸及び
／又は塩の溶液やクエン酸及び／又はその塩の溶液等が
好ましく例示できる。この中では、刺激発現が極めて少
ないことからクエン酸及び／又は塩乃至はその溶液を用
いるのが特に好ましい。又、クエン酸及び／又は塩を使
用することにより、熱の発生も心地よいレベルにコント
ロールすることが可能である。本発明の化粧料に於け
る、これら酸性物資の好ましい含有量は、使用直前の形
態に於いて、１〜１０重量％であり、更に好ましくは２
〜８重量％である。これは少なすぎると、熱発生量が少
なすぎ心地よさが発現しない場合があり、多すぎると熱
くなりすぎたり、過剰な酸による刺激が発現したりする
場合があるので、前記範囲がこのましいのである。(2) Acidic substance which is an essential component of the cosmetic of the present invention The cosmetic of the present invention contains an acidic substance as an essential component. As the acidic substance that can be used in the present invention, any substance can be used without particular limitation as long as it reacts with the amphoteric substance to form a salt. For example, a dilute mineral acid such as dilute hydrochloric acid and / or a salt solution or the like can be used. A preferred example is a solution of citric acid and / or a salt thereof. Among them, citric acid and / or a salt or a solution thereof is particularly preferable because the expression of a stimulus is extremely small. Also, by using citric acid and / or salts, it is possible to control the generation of heat to a comfortable level. The preferred content of these acidic substances in the cosmetic of the present invention is 1 to 10% by weight, more preferably 2 to 10% by weight in the form immediately before use.
８8% by weight. If the amount is too small, the amount of heat generated may be too small and the comfort may not be exhibited.If the amount is too large, the heat may be too hot or the irritation due to the excessive acid may occur, so the above range is preferable. It is.
【０００８】（３）本発明の化粧料 本発明の化粧料は、上記必須成分を溶液で混合しない形
態で含有することを特徴とする。これは、両者が溶液形
態で混合すると、中和塩形成反応が起こってしまうから
である。従って、本発明の化粧料は少なくとも２剤から
なる、多剤タイプの化粧料であり、用時にこれらの構成
成分を一様に混合して使用する形態をとる。この様な形
態としては、１）両性物質と固形の酸性物質とを水の介
在しない剤形で存在させ、使用時に水を含む組成物を加
えて使用する方法や２）両性物質と酸性物質とを別々の
剤形のものに含有させ使用時にこれらの剤形のものを混
合して使用するもの（但し、水分は片方もしくは両方の
剤形に存在する。）等が考えられる。使用勝手として
は、酸性物質を含む組成物と両性物質を含む組成物の２
種の組成物からなる２剤形のものであって、これらの組
成物の少なくとも１方が水溶液であるような形態が、速
やかに組成物全部で反応が起こるので特に好ましい。
又、化粧料としては、温感効果が必要な、或いは好まし
い種類の化粧料であれば特段の限定はされずに適用する
ことができ、パック化粧料やマッサージ化粧料などが好
適に例示できる。この中では。パック化粧料が特に好ま
しい。更にパック化粧料としては、フォーム状のものが
断熱効果が高いので、本発明の適用対象としては特に好
ましい。環境行政上、ノンガスタイプであると更に好ま
しい。この様なノンガスタイプのものとしては、用時に
炭酸塩と酸性成分とを混合させて炭酸ガスを発生させる
ような剤形のものが好ましく例示できる。(3) Cosmetic of the present invention The cosmetic of the present invention is characterized in that the above-mentioned essential components are contained in a form that is not mixed with a solution. This is because if both are mixed in a solution form, a neutralization salt forming reaction will occur. Therefore, the cosmetic of the present invention is a multi-part type cosmetic comprising at least two agents, and takes a form in which these components are uniformly mixed and used at the time of use. Examples of such a form include 1) a method in which an amphoteric substance and a solid acidic substance are present in a dosage form that does not involve water, and a composition containing water is added at the time of use, and 2) an amphoteric substance and an acidic substance are used. Are contained in separate dosage forms, and these dosage forms are mixed and used at the time of use (however, water is present in one or both dosage forms). As for the convenience of use, the composition containing an acidic substance and the composition containing an amphoteric substance are two types.
It is particularly preferred that the composition is a two-dose form composed of various kinds of compositions, in which at least one of these compositions is an aqueous solution, since the reaction takes place quickly in the whole composition.
Further, as the cosmetics, any cosmetics which require or have a warm feeling effect can be applied without any particular limitation, and pack cosmetics and massage cosmetics can be suitably exemplified. In this. Pack cosmetics are particularly preferred. Further, as a pack cosmetic, a foam-like cosmetic is particularly preferable as an application target of the present invention because of its high heat insulating effect. In terms of environmental administration, a non-gas type is more preferable. As such a non-gas type, a dosage form which generates a carbon dioxide gas by mixing a carbonate and an acidic component at the time of use can be preferably exemplified.
【０００９】本発明の化粧料では、上記必須の成分以外
に、通常化粧料で使用される任意成分を含有することが
できる。この様な任意成分としては、スクワラン、ワセ
リン、マイクロクリスタリンワックス等の炭化水素類、
ホホバ油、カルナウバワックス，オレイン酸オクチルド
デシル等のエステル類、オリーブ油、牛脂、椰子油等の
トリグリセライド類、ステアリン酸、オレイン酸、リチ
ノレイン酸等の脂肪酸、オレイルアルコール、ステアリ
ルアルコール、オクチルドデカノール等の高級アルコー
ル、スルホコハク酸エステルやポリオキシエチレンアル
キル硫酸ナトリウム等のアニオン界面活性剤類、アルキ
ルベタイン塩等の両性界面活性剤類、ジアルキルアンモ
ニウム塩等のカチオン界面活性剤類、ソルビタン脂肪酸
エステル、脂肪酸モノグリセライド、これらのポリオキ
シエチレン付加物、ポリオキシエチレンアルキルエーテ
ル、ポリオキシエチレン脂肪酸エステル等の非イオン界
面活性剤類、ポリエチレングリコール、グリセリン、
１，３−ブタンジオール等の多価アルコール類、増粘・
ゲル化剤、酸化防止剤、紫外線吸収剤、色剤、防腐剤、
粉体等を好ましく例示することができる．これらの任意
の成分の内、特に好ましいものは水との混合時に熱を発
生するグリセリン、ポリエチレングリコール、１，３−
ブタンジオール、ジプロピレングリコール、ジグリセリ
ンなどの多価アルコールであり、中でもポリエチレング
リコールが好ましく、ポリエチレングリコールでは平均
分子量が１００〜６００のものが特に好ましい。その好
ましい含有量は、使用直前の形態に於いて、３０〜７０
重量％であり、更に好ましくは４０〜６０重量％であ
る。又、前述の炭酸塩と酸性成分の反応型ノンガスタイ
プ化粧料に於いては、炭酸ナトリウムや炭酸水素ナトリ
ウムの様な炭酸塩を０．５〜１０重量％、更に好ましく
は１〜５重量％含有することが特に好ましい。本発明の
化粧料は、これら必須の成分と任意成分とを常法に従っ
て処理することにより製造することができる。The cosmetic of the present invention may contain, in addition to the above-mentioned essential components, optional components usually used in cosmetics. Such optional components include hydrocarbons such as squalane, petrolatum, microcrystalline wax,
Esters such as jojoba oil, carnauba wax, octyldodecyl oleate, triglycerides such as olive oil, tallow, coconut oil, etc., fatty acids such as stearic acid, oleic acid and ritinoleic acid, oleyl alcohol, stearyl alcohol, octyldodecanol and the like Higher alcohols, anionic surfactants such as sulfosuccinates and sodium polyoxyethylene alkyl sulfate, amphoteric surfactants such as alkyl betaine salts, cationic surfactants such as dialkylammonium salts, sorbitan fatty acid esters, fatty acid monoglycerides, These polyoxyethylene adducts, polyoxyethylene alkyl ethers, nonionic surfactants such as polyoxyethylene fatty acid esters, polyethylene glycol, glycerin,
Polyhydric alcohols such as 1,3-butanediol,
Gelling agents, antioxidants, ultraviolet absorbers, coloring agents, preservatives,
Preferred examples include powders. Among these optional components, particularly preferred are glycerin, polyethylene glycol, and 1,3-, which generate heat when mixed with water.
Polyhydric alcohols such as butanediol, dipropylene glycol, and diglycerin are preferable, and polyethylene glycol is particularly preferable, and polyethylene glycol having an average molecular weight of 100 to 600 is particularly preferable. The preferred content is 30 to 70 in the form immediately before use.
%, More preferably 40 to 60% by weight. Further, in the non-gas type cosmetic composition of the above-mentioned reaction type of a carbonate and an acidic component, a carbonate such as sodium carbonate or sodium hydrogencarbonate is contained in an amount of 0.5 to 10% by weight, more preferably 1 to 5% by weight. It is particularly preferred to do so. The cosmetic of the present invention can be produced by treating these essential components and optional components according to a conventional method.
【００１０】[0010]
【実施例】以下に実施例を挙げて、本発明について更に
詳細に説明をするが、本発明がこれら実施例にのみ限定
を受けないことは言うまでもない。EXAMPLES The present invention will be described in more detail with reference to the following examples, but it goes without saying that the present invention is not limited only to these examples.
【００１１】＜実施例１＞下記に示す処方に従って、ピ
ールオフタイプのパック料を作製した。即ち、イの成分を
良く混練りし、容器に詰め第１剤とし、ロの成分を室温
で攪拌可溶化し、第２剤とした。この１剤と２剤は使用
直前に良く混合した後、顔に伸ばして用いた。このパッ
ク料について、専門パネラー５名を用いて、比較例とし
て酸化亜鉛をタルクに置換したもの（比較例１）とクエ
ン酸を塩化ナトリウムに置換したもの（比較例２）を用
い、パック時の温感、パック時の心地よさを＋＋：非常
によい、＋：良い、±：やや良い、−：良くないの基準
で判定した。結果を表１に出現例数として示す。これよ
り、本発明の化粧料である、パック化粧料は、優れた温
感を創出し、もって、非常に心地よい使い心地であるこ
とが明白である。 イ） 酢酸ビニルエマルジョン（固形分６０％） ５０ 重量部 ポリエチレングリコール４００ ５ 重量部 タルク ５ 重量部 微粒子酸化亜鉛 １４．８重量部 メチルパラベン ０．２重量部 ロ） 水 ２０ 重量部 クエン酸 ５ 重量部Example 1 A peel-off type pack was prepared according to the following formulation. That is, the component (a) was kneaded well, packed in a container to obtain a first agent, and the component (b) was stirred and solubilized at room temperature to obtain a second agent. The first and second agents were mixed well immediately before use, and then spread over the face before use. Using 5 packs of expert panelists, as a comparative example, a pack in which zinc oxide was replaced with talc (Comparative Example 1) and a pack in which citric acid was replaced with sodium chloride (Comparative Example 2) were used. The feeling of warmth and the comfort at the time of packing were determined on the basis of ++: very good, +: good, ±: slightly good,-: not good. The results are shown in Table 1 as the number of appearance cases. From this, it is clear that the pack cosmetic, which is the cosmetic of the present invention, creates an excellent warm feeling and is therefore very comfortable to use. A) Vinyl acetate emulsion (solid content 60%) 50 parts by weight Polyethylene glycol 400 5 parts by weight Talc 5 parts by weight Fine particle zinc oxide 14.8 parts by weight Methyl paraben 0.2 parts by weight b) Water 20 parts by weight Citric acid 5 parts by weight
【００１２】[0012]
【表１】 [Table 1]
【００１３】＜実施例２＞下記に示す処方に従って、マ
ッサージクリームを作製した。即ち、イの成分を良く混
練りしクリームを作製し、第１剤とし、ロの成分を室温
で攪拌、可溶化し第２剤とした。このものを使用直前に
良く攪拌、混合しマッサージクリームとした。このもの
を用いて、実施例１と同様に、酸化亜鉛をタルクに置換
したもの（比較例３）とクエン酸を塩化ナトリウムに置
換したもの（比較例４）とともに評価した。この結果を
出現例数として表２に示す。これより、本発明の化粧料
は、マッサージクリームに於いてもパック同様、優れた
温感効果と心地よさを提供していることがわかる。 イ） ワセリン ５０ 重量部 ポリオキシエチレン（２０）オレイルエーテル ４ 重量部 酸化亜鉛 １５ 重量部 ポリエチレングリコール４００ ６ 重量部 ロ） 水 ２０ 重量部 クエン酸 ５ 重量部Example 2 A massage cream was prepared according to the following recipe. That is, the component (a) was kneaded well to prepare a cream and used as a first agent. The component (b) was stirred and solubilized at room temperature to obtain a second agent. This was thoroughly stirred and mixed immediately before use to give a massage cream. This was evaluated in the same manner as in Example 1 together with the one in which zinc oxide was replaced by talc (Comparative Example 3) and the one in which citric acid was replaced by sodium chloride (Comparative Example 4). The results are shown in Table 2 as the number of appearance cases. From this, it can be seen that the cosmetic of the present invention provides excellent warming effect and comfort in a massage cream as well as in a pack. A) Vaseline 50 parts by weight Polyoxyethylene (20) oleyl ether 4 parts by weight Zinc oxide 15 parts by weight Polyethylene glycol 400 6 parts by weight b) Water 20 parts by weight Citric acid 5 parts by weight
【００１４】[0014]
【表２】 [Table 2]
【００１５】＜実施例３＞以下に示す処方に従って、ノ
ンガスタイプのフォーム状パック化粧料を作製した。即
ち、イの成分は良く攪拌、混練りして第１剤とした。
又、ロの成分は攪拌、可溶化して第２剤とした。これら
を使用直前に混合し、発泡させフォームを形成させてパ
ック剤として用いた。このものを実施例１のパック料を
対照に、心地よさを＋＋：実施例１に比較して非常によ
い、＋：実施例１に比較して良い、±：実施例１に比較
してやや良い、−：実施例１に比較して良くないの基準
で評価した。（専門パネラー、５名）結果は＋＋：２
名、＋：２名、±：１名であり、本発明の化粧料の剤形
としては、この様なフォーム・パック化粧料が好ましい
ことがわかる。 イ） ベヘニルアルコール １ 重量部 セタノール １．５重量部 コレステロール １ 重量部 デカグリセリンモノオレート １．５重量部 キサンタンガム ０．４重量部 ポリエチレングリコール ４００ ４６ 重量部 重曹 ３ 重量部 酸化亜鉛 １１．６重量部 タルク ７ 重量部 ロ） 水 ２２．６重量部 クエン酸 ４．３重量部 クエン酸ナトリウム ０．１重量部Example 3 A non-gas type foam pack cosmetic was prepared according to the following formulation. That is, the component (a) was well stirred and kneaded to obtain a first agent.
The component (b) was stirred and solubilized to obtain a second agent. These were mixed immediately before use, foamed to form a foam, and used as a pack. Compared with the pack material of Example 1, this product has a comfortableness of ++: very good as compared with Example 1, +: well as compared with Example 1, ±: slightly better than Example 1. ,-: Evaluation was made based on the criteria of not good compared to Example 1. (Specialized panelists, 5 people) The result is ++: 2
Name, +: 2 persons, ±: 1 person, indicating that such a foam / pack cosmetic is preferable as the dosage form of the cosmetic of the present invention. B) Behenyl alcohol 1 part by weight Cetanol 1.5 parts by weight Cholesterol 1 part by weight Decaglycerin monooleate 1.5 parts by weight Xanthan gum 0.4 parts by weight Polyethylene glycol 400 46 parts by weight Baking soda 3 parts by weight Zinc oxide 11.6 parts by weight Talc 7 Parts by weight b) water 22.6 parts by weight citric acid 4.3 parts by weight sodium citrate 0.1 part by weight
【００１６】＜実施例４〜７＞実施例３と同様に多価ア
ルコールの種類を変えて、実施例３と同様に検討を行っ
た。結果を、表３に示す。これより、本発明の化粧料に
於いては、多価アルコールとしては、平均分子量が１０
０〜６００のポリエチレングリコールが好ましいことが
わかる。 イ） ベヘニルアルコール １ 重量部 セタノール １．５重量部 コレステロール １ 重量部 デカグリセリンモノオレート １．５重量部 キサンタンガム ０．４重量部 多価アルコール＊ ４６ 重量部 重曹 ３ 重量部 酸化亜鉛 １１．６重量部 タルク ７ 重量部 ロ） 水 ２２．６重量部 クエン酸 ４．３重量部 クエン酸ナトリウム ０．１重量部 ＊詳細は、表３に記す。<Examples 4 to 7> In the same manner as in Example 3, the type of polyhydric alcohol was changed, and the same study as in Example 3 was conducted. Table 3 shows the results. Accordingly, in the cosmetic of the present invention, the polyhydric alcohol has an average molecular weight of 10
It turns out that polyethylene glycol of 0-600 is preferable. A) Behenyl alcohol 1 part by weight Cetanol 1.5 parts by weight Cholesterol 1 part by weight Decaglycerin monooleate 1.5 parts by weight Xanthan gum 0.4 parts by weight Polyhydric alcohol * 46 parts by weight Baking soda 3 parts by weight Zinc oxide 11.6 parts by weight talc 7 parts by weight b) Water 22.6 parts by weight Citric acid 4.3 parts by weight Sodium citrate 0.1 part by weight * Details are shown in Table 3.
【００１７】[0017]
【表３】 [Table 3]
【００１８】＜実施例８＞以下に示す処方に従って、ノ
ンガスタイプのフォーム状パック化粧料を作製した。即
ち、イの成分は良く攪拌、混練りして第１剤とした。
又、ロの成分は攪拌、可溶化して第２剤とした。これら
を使用直前に混合し、発泡させフォームを形成させてパ
ック剤として用いた。このものは、実施例３にはやや及
ばないが、温感のある、心地いよいパックであった。こ
れより、酸と反応する金属化合物及び／又は金属水酸化
物の含有量としては、５重量％以上が好ましいことがわ
かる。 イ） ベヘニルアルコール １ 重量部 セタノール １．５重量部 コレステロール １ 重量部 デカグリセリンモノオレート １．５重量部 キサンタンガム ０．４重量部 ポリエチレングリコール ４００ ４６ 重量部 重曹 ３ 重量部 酸化亜鉛 ５．６重量部 タルク １３ 重量部 ロ） 水 ２２．６重量部 クエン酸 ２．３重量部 クエン酸ナトリウム ２．１重量部Example 8 A non-gas foam cosmetic pack was prepared according to the following formulation. That is, the component (a) was well stirred and kneaded to obtain a first agent.
The component (b) was stirred and solubilized to obtain a second agent. These were mixed immediately before use, foamed to form a foam, and used as a pack. This was a warm, comfortable pack that was slightly inferior to Example 3. This indicates that the content of the metal compound and / or metal hydroxide that reacts with the acid is preferably 5% by weight or more. B) Behenyl alcohol 1 part by weight Cetanol 1.5 parts by weight Cholesterol 1 part by weight Decaglycerin monooleate 1.5 parts by weight Xanthan gum 0.4 parts by weight Polyethylene glycol 400 46 parts by weight Baking soda 3 parts by weight Zinc oxide 5.6 parts by weight Talc 13 Parts by weight b) water 22.6 parts by weight citric acid 2.3 parts by weight sodium citrate 2.1 parts by weight
【００１９】＜実施例９＞以下に示す処方に従って、ノ
ンガスタイプのフォーム状パック化粧料を作製した。即
ち、イの成分は良く攪拌、混練りして第１剤とした。
又、ロの成分は攪拌、可溶化して第２剤とした。これら
を使用直前に混合し、発泡させフォームを形成させてパ
ック剤として用いた。このものは、実施例３にはやや及
ばないが、温感のある、心地いよいパックであった。こ
れより、酸と反応する金属化合物及び／又は金属水酸化
物の含有量としては、１５重量％以下が好ましいことが
わかる。 イ） ベヘニルアルコール １ 重量部 セタノール １．５重量部 コレステロール １ 重量部 デカグリセリンモノオレート １．５重量部 キサンタンガム ０．４重量部 ポリエチレングリコール ４００ ４６ 重量部 重曹 ３ 重量部 酸化亜鉛 １４．６重量部 タルク ４ 重量部 ロ） 水 ２１．６重量部 クエン酸 ５．３重量部 クエン酸ナトリウム ０．１重量部Example 9 A non-gas type foam pack cosmetic was prepared according to the following formulation. That is, the component (a) was well stirred and kneaded to obtain a first agent.
The component (b) was stirred and solubilized to obtain a second agent. These were mixed immediately before use, foamed to form a foam, and used as a pack. This was a warm, comfortable pack that was slightly inferior to Example 3. This indicates that the content of the metal compound and / or metal hydroxide that reacts with the acid is preferably 15% by weight or less. A) Behenyl alcohol 1 part by weight Cetanol 1.5 parts by weight Cholesterol 1 part by weight Decaglycerin monooleate 1.5 parts by weight Xanthan gum 0.4 parts by weight Polyethylene glycol 400 46 parts by weight Baking soda 3 parts by weight Zinc oxide 14.6 parts by weight Talc 4 Parts by weight b) water 21.6 parts by weight citric acid 5.3 parts by weight sodium citrate 0.1 part by weight
【００２０】＜実施例１０＞以下に示す処方に従って、
ノンガスタイプのフォーム状パック化粧料を作製した。
即ち、イの成分は良く攪拌、混練りして第１剤とした。
又、ロの成分は攪拌、可溶化して第２剤とした。これら
を使用直前に混合し、発泡させフォームを形成させてパ
ック剤として用いた。このものを実施例３のパック料を
対照に、心地よさを＋＋：実施例３同程度によい、＋：
実施例３に比較してやや劣るが発熱パックとしてはかな
り良い、±：実施例３に比較して劣るが発熱パックとし
て浜まである、−：発熱パックとして好ましくないの基
準で評価した。（専門パネラー、５名）結果は＋＋：３
名、＋：２名であり、本発明の化粧料には酸と反応する
金属酸化物として酸化マグネシウムも使用しうることが
わかる。 イ） ベヘニルアルコール １ 重量部 セタノール １．５重量部 コレステロール １ 重量部 デカグリセリンモノオレート １．５重量部 キサンタンガム ０．４重量部 ポリエチレングリコール ４００ ４６ 重量部 重曹 ３ 重量部 酸化マグネシウム １１．６重量部 タルク ７ 重量部 ロ） 水 ２２．６重量部 クエン酸 ４．３重量部 クエン酸ナトリウム ０．１重量部<Example 10> According to the following formulation,
A non-gas type foam pack cosmetic was produced.
That is, the component (a) was well stirred and kneaded to obtain a first agent.
The component (b) was stirred and solubilized to obtain a second agent. These were mixed immediately before use, foamed to form a foam, and used as a pack. Compared to the pack fee of Example 3, this product has a comfort of ++: as good as Example 3, +:
Slightly inferior to Example 3, but quite good as a heat-generating pack, ±: Inferior to Example 3, but up to the beach as a heat-generating pack,-: Unfavorable as a heat-generating pack. (Specialized panelists, 5 people) The result is ++: 3
Name, +: 2 persons, indicating that magnesium oxide can also be used as a metal oxide that reacts with an acid in the cosmetic of the present invention. A) Behenyl alcohol 1 part by weight Cetanol 1.5 parts by weight Cholesterol 1 part by weight Decaglycerin monooleate 1.5 parts by weight Xanthan gum 0.4 parts by weight Polyethylene glycol 400 46 parts by weight Baking soda 3 parts by weight Magnesium oxide 11.6 parts by weight Talc 7 Parts by weight b) water 22.6 parts by weight citric acid 4.3 parts by weight sodium citrate 0.1 part by weight
【００２１】[0021]
【発明の効果】本発明によれば、充分且つ適切な熱量を
発生し、心地よい温感を有する化粧料を提供することが
できる。According to the present invention, it is possible to provide a cosmetic that generates a sufficient and appropriate amount of heat and has a comfortable warm feeling.
───────────────────────────────────────────────────── フロントページの続き Ｆターム(参考） 4C083 AB211 AB212 AB312 AB432 AC012 AC072 AC122 AC182 AC301 AC302 AC422 AC482 AD042 AD092 AD352 AD492 CC07 DD08 DD22 DD27 DD31 EE06 EE07 EE11 FF05 ──────────────────────────────────────────────────続 き Continued on the front page F term (reference) 4C083 AB211 AB212 AB312 AB432 AC012 AC072 AC122 AC182 AC301 AC302 AC422 AC482 AD042 AD092 AD352 AD492 CC07 DD08 DD22 DD27 DD31 EE06 EE07 EE11 FF05
Claims (6)
水酸化物と酸性物質とを水溶液として混合しない形態で
含有する、化粧料。1. A cosmetic comprising a metal compound and / or metal hydroxide that reacts with an acid and an acidic substance in a form that is not mixed as an aqueous solution.
水酸化物が酸化亜鉛及び／又は酸化マグネシウムである
ことを特徴とする、請求項１に記載の化粧料。2. The cosmetic according to claim 1, wherein the metal compound and / or metal hydroxide that reacts with an acid is zinc oxide and / or magnesium oxide.
ことを特徴とする、請求項１又は２に記載の化粧料。3. The cosmetic according to claim 1, wherein the acidic substance is citric acid and / or a salt.
項１〜３何れか１項に記載の化粧料。4. The cosmetic according to claim 1, which is a pack.
特徴とする、請求項１〜４何れか１項に記載の化粧料。5. The cosmetic according to claim 1, which is a non-gas foam cosmetic.
る、請求項１〜５何れか１項に記載の化粧料。6. The cosmetic according to claim 1, wherein the cosmetic has a warm feeling when used.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP19115499A JP4058199B2 (en) | 1999-07-06 | 1999-07-06 | Warm feeling pack |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP19115499A JP4058199B2 (en) | 1999-07-06 | 1999-07-06 | Warm feeling pack |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2001019606A true JP2001019606A (en) | 2001-01-23 |
| JP2001019606A5 JP2001019606A5 (en) | 2006-07-27 |
| JP4058199B2 JP4058199B2 (en) | 2008-03-05 |
Family
ID=16269810
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP19115499A Expired - Lifetime JP4058199B2 (en) | 1999-07-06 | 1999-07-06 | Warm feeling pack |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP4058199B2 (en) |
Cited By (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7255869B2 (en) | 2001-10-30 | 2007-08-14 | The Procter & Gamble Company | Anhydrous cosmetic compositions containing polyols |
| US7704518B2 (en) | 2003-08-04 | 2010-04-27 | Foamix, Ltd. | Foamable vehicle and pharmaceutical compositions thereof |
| US7820145B2 (en) | 2003-08-04 | 2010-10-26 | Foamix Ltd. | Oleaginous pharmaceutical and cosmetic foam |
| US8486376B2 (en) | 2002-10-25 | 2013-07-16 | Foamix Ltd. | Moisturizing foam containing lanolin |
| US20130232807A1 (en) * | 2011-05-12 | 2013-09-12 | Michael E. Robert | Hand Dryer With Sanitizing Ionization Assembly |
| US8618081B2 (en) | 2009-10-02 | 2013-12-31 | Foamix Ltd. | Compositions, gels and foams with rheology modulators and uses thereof |
| US8741265B2 (en) | 2002-10-25 | 2014-06-03 | Foamix Ltd. | Penetrating pharmaceutical foam |
| US8795635B2 (en) | 2006-11-14 | 2014-08-05 | Foamix Ltd. | Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses |
| US8795693B2 (en) | 2003-08-04 | 2014-08-05 | Foamix Ltd. | Compositions with modulating agents |
| US8900553B2 (en) | 2007-12-07 | 2014-12-02 | Foamix Pharmaceuticals Ltd. | Oil and liquid silicone foamable carriers and formulations |
| US9072667B2 (en) | 2009-07-29 | 2015-07-07 | Foamix Pharmaceuticals Ltd. | Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses |
| US9167813B2 (en) | 2009-07-29 | 2015-10-27 | Foamix Pharmaceuticals Ltd. | Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses |
| US9211259B2 (en) | 2002-11-29 | 2015-12-15 | Foamix Pharmaceuticals Ltd. | Antibiotic kit and composition and uses thereof |
| US9265725B2 (en) | 2002-10-25 | 2016-02-23 | Foamix Pharmaceuticals Ltd. | Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof |
| US9439857B2 (en) | 2007-11-30 | 2016-09-13 | Foamix Pharmaceuticals Ltd. | Foam containing benzoyl peroxide |
| US9539208B2 (en) | 2002-10-25 | 2017-01-10 | Foamix Pharmaceuticals Ltd. | Foam prepared from nanoemulsions and uses |
| US9622947B2 (en) | 2002-10-25 | 2017-04-18 | Foamix Pharmaceuticals Ltd. | Foamable composition combining a polar solvent and a hydrophobic carrier |
| US9662298B2 (en) | 2007-08-07 | 2017-05-30 | Foamix Pharmaceuticals Ltd. | Wax foamable vehicle and pharmaceutical compositions thereof |
| US9668972B2 (en) | 2002-10-25 | 2017-06-06 | Foamix Pharmaceuticals Ltd. | Nonsteroidal immunomodulating kit and composition and uses thereof |
| US9713643B2 (en) | 2002-10-25 | 2017-07-25 | Foamix Pharmaceuticals Ltd. | Foamable carriers |
| US9849142B2 (en) | 2009-10-02 | 2017-12-26 | Foamix Pharmaceuticals Ltd. | Methods for accelerated return of skin integrity and for the treatment of impetigo |
| US9884017B2 (en) | 2009-04-28 | 2018-02-06 | Foamix Pharmaceuticals Ltd. | Foamable vehicles and pharmaceutical compositions comprising aprotic polar solvents and uses thereof |
| US10398641B2 (en) | 2016-09-08 | 2019-09-03 | Foamix Pharmaceuticals Ltd. | Compositions and methods for treating rosacea and acne |
| US10821077B2 (en) | 2002-10-25 | 2020-11-03 | Foamix Pharmaceuticals Ltd. | Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8512718B2 (en) | 2000-07-03 | 2013-08-20 | Foamix Ltd. | Pharmaceutical composition for topical application |
| US8119150B2 (en) | 2002-10-25 | 2012-02-21 | Foamix Ltd. | Non-flammable insecticide composition and uses thereof |
| US8119109B2 (en) | 2002-10-25 | 2012-02-21 | Foamix Ltd. | Foamable compositions, kits and methods for hyperhidrosis |
| US8900554B2 (en) | 2002-10-25 | 2014-12-02 | Foamix Pharmaceuticals Ltd. | Foamable composition and uses thereof |
| US7575739B2 (en) | 2003-04-28 | 2009-08-18 | Foamix Ltd. | Foamable iodine composition |
| US8486374B2 (en) | 2003-08-04 | 2013-07-16 | Foamix Ltd. | Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses |
| WO2010041141A2 (en) | 2008-10-07 | 2010-04-15 | Foamix Ltd. | Oil-based foamable carriers and formulations |
| WO2009090558A2 (en) | 2008-01-14 | 2009-07-23 | Foamix Ltd. | Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS60215606A (en) * | 1984-04-12 | 1985-10-29 | Kao Corp | Pack preparation |
| JPH08268828A (en) * | 1995-03-31 | 1996-10-15 | Shiseido Co Ltd | Pack cosmetic |
| JP2000344617A (en) * | 1999-06-04 | 2000-12-12 | Kao Corp | Thermotherapeutic composition |
-
1999
- 1999-07-06 JP JP19115499A patent/JP4058199B2/en not_active Expired - Lifetime
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS60215606A (en) * | 1984-04-12 | 1985-10-29 | Kao Corp | Pack preparation |
| JPH08268828A (en) * | 1995-03-31 | 1996-10-15 | Shiseido Co Ltd | Pack cosmetic |
| JP2000344617A (en) * | 1999-06-04 | 2000-12-12 | Kao Corp | Thermotherapeutic composition |
Cited By (64)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7255869B2 (en) | 2001-10-30 | 2007-08-14 | The Procter & Gamble Company | Anhydrous cosmetic compositions containing polyols |
| US11033491B2 (en) | 2002-10-25 | 2021-06-15 | Vyne Therapeutics Inc. | Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof |
| US9539208B2 (en) | 2002-10-25 | 2017-01-10 | Foamix Pharmaceuticals Ltd. | Foam prepared from nanoemulsions and uses |
| US9492412B2 (en) | 2002-10-25 | 2016-11-15 | Foamix Pharmaceuticals Ltd. | Penetrating pharmaceutical foam |
| US9713643B2 (en) | 2002-10-25 | 2017-07-25 | Foamix Pharmaceuticals Ltd. | Foamable carriers |
| US10322085B2 (en) | 2002-10-25 | 2019-06-18 | Foamix Pharmaceuticals Ltd. | Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof |
| US8741265B2 (en) | 2002-10-25 | 2014-06-03 | Foamix Ltd. | Penetrating pharmaceutical foam |
| US9668972B2 (en) | 2002-10-25 | 2017-06-06 | Foamix Pharmaceuticals Ltd. | Nonsteroidal immunomodulating kit and composition and uses thereof |
| US9265725B2 (en) | 2002-10-25 | 2016-02-23 | Foamix Pharmaceuticals Ltd. | Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof |
| US8486376B2 (en) | 2002-10-25 | 2013-07-16 | Foamix Ltd. | Moisturizing foam containing lanolin |
| US10117812B2 (en) | 2002-10-25 | 2018-11-06 | Foamix Pharmaceuticals Ltd. | Foamable composition combining a polar solvent and a hydrophobic carrier |
| US10821077B2 (en) | 2002-10-25 | 2020-11-03 | Foamix Pharmaceuticals Ltd. | Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof |
| US9622947B2 (en) | 2002-10-25 | 2017-04-18 | Foamix Pharmaceuticals Ltd. | Foamable composition combining a polar solvent and a hydrophobic carrier |
| US9211259B2 (en) | 2002-11-29 | 2015-12-15 | Foamix Pharmaceuticals Ltd. | Antibiotic kit and composition and uses thereof |
| US9101662B2 (en) | 2003-08-04 | 2015-08-11 | Foamix Pharmaceuticals Ltd. | Compositions with modulating agents |
| US9050253B2 (en) | 2003-08-04 | 2015-06-09 | Foamix Pharmaceuticals Ltd. | Oleaginous pharmaceutical and cosmetic foam |
| US7820145B2 (en) | 2003-08-04 | 2010-10-26 | Foamix Ltd. | Oleaginous pharmaceutical and cosmetic foam |
| US8795693B2 (en) | 2003-08-04 | 2014-08-05 | Foamix Ltd. | Compositions with modulating agents |
| US7704518B2 (en) | 2003-08-04 | 2010-04-27 | Foamix, Ltd. | Foamable vehicle and pharmaceutical compositions thereof |
| US9636405B2 (en) | 2003-08-04 | 2017-05-02 | Foamix Pharmaceuticals Ltd. | Foamable vehicle and pharmaceutical compositions thereof |
| US8795635B2 (en) | 2006-11-14 | 2014-08-05 | Foamix Ltd. | Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses |
| US9682021B2 (en) | 2006-11-14 | 2017-06-20 | Foamix Pharmaceuticals Ltd. | Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses |
| US10369102B2 (en) | 2007-08-07 | 2019-08-06 | Foamix Pharmaceuticals Ltd. | Wax foamable vehicle and pharmaceutical compositions thereof |
| US9662298B2 (en) | 2007-08-07 | 2017-05-30 | Foamix Pharmaceuticals Ltd. | Wax foamable vehicle and pharmaceutical compositions thereof |
| US11103454B2 (en) | 2007-08-07 | 2021-08-31 | Vyne Therapeutics Inc. | Wax foamable vehicle and pharmaceutical compositions thereof |
| US9439857B2 (en) | 2007-11-30 | 2016-09-13 | Foamix Pharmaceuticals Ltd. | Foam containing benzoyl peroxide |
| US9549898B2 (en) | 2007-12-07 | 2017-01-24 | Foamix Pharmaceuticals Ltd. | Oil and liquid silicone foamable carriers and formulations |
| US9161916B2 (en) | 2007-12-07 | 2015-10-20 | Foamix Pharmaceuticals Ltd. | Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof |
| US8900553B2 (en) | 2007-12-07 | 2014-12-02 | Foamix Pharmaceuticals Ltd. | Oil and liquid silicone foamable carriers and formulations |
| US9795564B2 (en) | 2007-12-07 | 2017-10-24 | Foamix Pharmaceuticals Ltd. | Oil-based foamable carriers and formulations |
| US11433025B2 (en) | 2007-12-07 | 2022-09-06 | Vyne Therapeutics Inc. | Oil foamable carriers and formulations |
| US9884017B2 (en) | 2009-04-28 | 2018-02-06 | Foamix Pharmaceuticals Ltd. | Foamable vehicles and pharmaceutical compositions comprising aprotic polar solvents and uses thereof |
| US10213384B2 (en) | 2009-04-28 | 2019-02-26 | Foamix Pharmaceuticals Ltd. | Foamable vehicles and pharmaceutical compositions comprising aprotic polar solvents and uses thereof |
| US10363216B2 (en) | 2009-04-28 | 2019-07-30 | Foamix Pharmaceuticals Ltd. | Foamable vehicles and pharmaceutical compositions comprising aprotic polar solvents and uses thereof |
| US10588858B2 (en) | 2009-04-28 | 2020-03-17 | Foamix Pharmaceuticals Ltd. | Foamable vehicles and pharmaceutical compositions comprising aprotic polar solvents and uses thereof |
| US9072667B2 (en) | 2009-07-29 | 2015-07-07 | Foamix Pharmaceuticals Ltd. | Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses |
| US9167813B2 (en) | 2009-07-29 | 2015-10-27 | Foamix Pharmaceuticals Ltd. | Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses |
| US9572775B2 (en) | 2009-07-29 | 2017-02-21 | Foamix Pharmaceuticals Ltd. | Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses |
| US10350166B2 (en) | 2009-07-29 | 2019-07-16 | Foamix Pharmaceuticals Ltd. | Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses |
| US11219631B2 (en) | 2009-07-29 | 2022-01-11 | Vyne Pharmaceuticals Inc. | Foamable compositions, breakable foams and their uses |
| US10092588B2 (en) | 2009-07-29 | 2018-10-09 | Foamix Pharmaceuticals Ltd. | Foamable compositions, breakable foams and their uses |
| US9849142B2 (en) | 2009-10-02 | 2017-12-26 | Foamix Pharmaceuticals Ltd. | Methods for accelerated return of skin integrity and for the treatment of impetigo |
| US10517882B2 (en) | 2009-10-02 | 2019-12-31 | Foamix Pharmaceuticals Ltd. | Method for healing of an infected acne lesion without scarring |
| US10322186B2 (en) | 2009-10-02 | 2019-06-18 | Foamix Pharmaceuticals Ltd. | Topical tetracycline compositions |
| US10137200B2 (en) | 2009-10-02 | 2018-11-27 | Foamix Pharmaceuticals Ltd. | Surfactant-free water-free foamable compositions, breakable foams and gels and their uses |
| US8618081B2 (en) | 2009-10-02 | 2013-12-31 | Foamix Ltd. | Compositions, gels and foams with rheology modulators and uses thereof |
| US9675700B2 (en) | 2009-10-02 | 2017-06-13 | Foamix Pharmaceuticals Ltd. | Topical tetracycline compositions |
| US10238746B2 (en) | 2009-10-02 | 2019-03-26 | Foamix Pharmaceuticals Ltd | Surfactant-free water-free foamable compositions, breakable foams and gels and their uses |
| US10213512B2 (en) | 2009-10-02 | 2019-02-26 | Foamix Pharmaceuticals Ltd. | Topical tetracycline compositions |
| US10463742B2 (en) | 2009-10-02 | 2019-11-05 | Foamix Pharmaceuticals Ltd. | Topical tetracycline compositions |
| US10265404B2 (en) | 2009-10-02 | 2019-04-23 | Foamix Pharmaceuticals Ltd. | Compositions, gels and foams with rheology modulators and uses thereof |
| US10029013B2 (en) | 2009-10-02 | 2018-07-24 | Foamix Pharmaceuticals Ltd. | Surfactant-free, water-free formable composition and breakable foams and their uses |
| US10610599B2 (en) | 2009-10-02 | 2020-04-07 | Foamix Pharmaceuticals Ltd. | Topical tetracycline compositions |
| US10086080B2 (en) | 2009-10-02 | 2018-10-02 | Foamix Pharmaceuticals Ltd. | Topical tetracycline compositions |
| US10821187B2 (en) | 2009-10-02 | 2020-11-03 | Foamix Pharmaceuticals Ltd. | Compositions, gels and foams with rheology modulators and uses thereof |
| US10835613B2 (en) | 2009-10-02 | 2020-11-17 | Foamix Pharmaceuticals Ltd. | Compositions, gels and foams with rheology modulators and uses thereof |
| US8945516B2 (en) | 2009-10-02 | 2015-02-03 | Foamix Pharmaceuticals Ltd. | Surfactant-free water-free foamable compositions, breakable foams and gels and their uses |
| US10946101B2 (en) | 2009-10-02 | 2021-03-16 | Vyne Therapeutics Inc. | Surfactant-free water-free foamable compositions, breakable foams and gels and their uses |
| US10967063B2 (en) | 2009-10-02 | 2021-04-06 | Vyne Therapeutics Inc. | Surfactant-free, water-free formable composition and breakable foams and their uses |
| US20130232807A1 (en) * | 2011-05-12 | 2013-09-12 | Michael E. Robert | Hand Dryer With Sanitizing Ionization Assembly |
| US9421291B2 (en) * | 2011-05-12 | 2016-08-23 | Fifth Third Bank | Hand dryer with sanitizing ionization assembly |
| US10398641B2 (en) | 2016-09-08 | 2019-09-03 | Foamix Pharmaceuticals Ltd. | Compositions and methods for treating rosacea and acne |
| US11324691B2 (en) | 2016-09-08 | 2022-05-10 | Journey Medical Corporation | Compositions and methods for treating rosacea and acne |
| US10849847B2 (en) | 2016-09-08 | 2020-12-01 | Foamix Pharamaceuticals Ltd. | Compositions and methods for treating rosacea and acne |
Also Published As
| Publication number | Publication date |
|---|---|
| JP4058199B2 (en) | 2008-03-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2001019606A (en) | Warmth sensory pack | |
| JP2001019606A5 (en) | ||
| JP2002047136A (en) | Exothermic foam cosmetic | |
| JP2006008574A (en) | Non-aqueous foam cosmetic imparting warm sensation | |
| JP2006273752A (en) | Oil-in-water type foam-containing cosmetic | |
| JPH1160460A (en) | Skin cosmetic | |
| JP2003089615A (en) | Pack cosmetic with marshmallow touch | |
| JP4294198B2 (en) | Foam composition with warm feeling | |
| JPH0826956A (en) | Deodorant cosmetic | |
| JP3242137B2 (en) | Oil-in-water solid cosmetics | |
| JP3352381B2 (en) | Whitening powder | |
| JP5690494B2 (en) | Solid bath composition | |
| JP2009161439A (en) | Bath agent | |
| JP3536220B2 (en) | Deodorant cosmetics | |
| JP2003335618A (en) | Wet powdery cosmetic | |
| JPH09301852A (en) | Gel composition | |
| WO2007089337A2 (en) | Cosmetic beads and method of making same | |
| JP4035086B2 (en) | Foam forming cosmetic | |
| JP4677125B2 (en) | Argepack with a cool feeling | |
| JPH09263528A (en) | Cosmetic | |
| JP2004175673A (en) | Sustained exothermic foam pack | |
| JP3476620B2 (en) | Bath composition | |
| JP2008162923A (en) | Method for producing bathing agent | |
| JP4714355B2 (en) | Argepack with reduced cooling | |
| JP2006001906A (en) | Cosmetic giving warm feeling |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20060613 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20060613 |
|
| RD03 | Notification of appointment of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7423 Effective date: 20060613 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20070718 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20070724 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20070904 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20071009 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20071017 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20071120 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20071217 |
|
| R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 Ref document number: 4058199 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20131221 Year of fee payment: 6 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| EXPY | Cancellation because of completion of term |